Share This Page
Drug Price Trends for NDC 62332-0742
✉ Email this page to a colleague
Average Pharmacy Cost for 62332-0742
Drug Name | NDC | Price/Unit ($) | Unit | Date |
---|---|---|---|---|
ACITRETIN 17.5 MG CAPSULE | 62332-0742-30 | 12.74832 | EACH | 2024-12-18 |
ACITRETIN 17.5 MG CAPSULE | 62332-0742-30 | 13.21276 | EACH | 2024-12-04 |
>Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 62332-0742
Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
---|---|---|---|---|---|---|---|
>Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
62332-0742 Market Analysis and Financial Projection
Market Analysis and Price Projections for the Drug NDC: 62332-0742
Introduction to National Drug Codes (NDCs)
The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. For the NDC 62332-0742, understanding this system is crucial for tracking, pricing, and regulatory compliance.
Understanding the NDC Directory
The FDA's NDC Directory is a comprehensive resource that contains information on all listed drugs in their final marketed form, including prescription, over-the-counter, approved, and unapproved drugs. This directory is updated daily and includes data elements such as the Drug Enforcement Administration schedule and pharmacological class[1][4].
Identifying the Drug
To analyze the market and project prices for the drug with NDC 62332-0742, you need to identify the drug's specifics:
- Labeler Code: The first segment of the NDC, which identifies the labeler (manufacturer, repackager, or relabeler).
- Product Code: The second segment, which identifies the specific strength, dosage form, and formulation.
- Package Code: The third segment, which identifies the package sizes and types[4].
Market Analysis
Historical Pricing Data
Reviewing historical pricing data from the NDC Directory and other sources is essential for understanding price trends. This data can help in identifying any patterns or fluctuations in the drug's price over time. For example, if the drug has seen consistent price increases or decreases, this could inform future price projections[2].
Regulatory Changes
Changes in regulatory policies can significantly impact pricing. For instance, updates to the Medicaid Drug Rebate Program or new FDA guidelines can alter the pricing mechanisms. Keeping track of these changes is vital for accurate price projections[2].
Market Demand and Competition
The demand for the drug and the level of competition in the market are critical factors. If the drug faces significant competition from generics or biosimilars, the price might be more stable or even decrease over time. Conversely, if the drug has a unique therapeutic benefit with little competition, prices could remain high or increase[2].
Technological Advancements
Technological advancements, such as the adoption of AI in drug development and manufacturing, can reduce costs and potentially lead to lower prices. Monitoring these advancements and their impact on the pharmaceutical industry is important for price projections[2].
Pricing Mechanisms
Average Manufacturer Price (AMP) and Unit Rebate Amount (URA)
For drugs covered under the Medicaid Drug Rebate Program, the 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure. This calculation is adjusted by the package size and case pack size to determine the final ceiling price[2].
Example Calculation
If the NDC 62332-0742 corresponds to a covered outpatient drug, the ceiling price would be calculated as follows:
- AMP: $X per unit
- URA: $Y per unit
- Package Size: Z units
- Case Pack Size: W packages
[ \text{340B Ceiling Price} = (\text{AMP} - \text{URA}) \times \text{Package Size} \times \text{Case Pack Size} ]
This calculation provides a baseline for the ceiling price, but actual market prices can vary based on various factors including market demand, competition, and regulatory changes[2].
Market Size and Growth Projections
The US pharmaceutical market is projected to grow significantly, from $846.72 billion in 2022 to $1.28 trillion by 2030, with a CAGR of 5.36%. This growth is driven by factors such as rising pharmaceutical production capacity, greater approvals of generic drugs, and escalating R&D investments[2].
Price Projections
Historical Data Analysis
Analyzing historical pricing data for the drug with NDC 62332-0742 can provide insights into price trends. For example, if the drug has historically seen annual price increases of 5%, this trend might continue unless influenced by other factors.
Regulatory Impact
Any upcoming regulatory changes, such as updates to reimbursement policies or new FDA guidelines, need to be considered in price projections. These changes can either increase or decrease the drug's price.
Market Dynamics
The level of competition and market demand will significantly influence the price. If the drug is facing increased competition from newer, more effective treatments, prices might decrease. Conversely, if the drug maintains a strong market position, prices could remain stable or increase.
Technological Impact
The adoption of new technologies in drug development and manufacturing can reduce costs. If these cost reductions are passed on to consumers, prices could decrease.
Example Scenario
If the drug with NDC 62332-0742 is widely used and has a high demand but faces significant competition from generics or biosimilars, the price might be more stable or even decrease over time. Here’s a hypothetical example:
- AMP: $100 per unit
- URA: $20 per unit
- Package Size: 10 units
- Case Pack Size: 5 packages
[ \text{340B Ceiling Price} = (100 - 20) \times 10 \times 5 = \$4000 ]
This calculation provides a baseline, but actual market prices can vary based on the factors mentioned above[2].
Key Takeaways
- NDC Directory: A critical resource for tracking and pricing drugs, updated daily by the FDA.
- Market Trends: The US pharmaceutical market is growing, with significant impacts from generics, biosimilars, and technological advancements.
- Pricing Mechanisms: AMP and URA are key in calculating ceiling prices for covered outpatient drugs.
- Market Growth: The US pharmaceutical market is projected to grow significantly by 2030.
- Price Projections: Historical data, regulatory changes, market demand, competition, and technological advancements influence price projections.
FAQs
What is the National Drug Code (NDC) and how is it used?
The National Drug Code (NDC) is a unique, three-segment number that serves as the FDA’s identifier for drugs. It is used for tracking, pricing, and regulatory compliance of pharmaceutical products in the U.S. market[1][4].
How is the 340B ceiling price calculated for a drug?
The 340B ceiling price is calculated by subtracting the Unit Rebate Amount (URA) from the Average Manufacturer Price (AMP) for the smallest unit of measure, adjusted by the package size and case pack size[2].
What factors influence price projections for pharmaceutical drugs?
Price projections are influenced by historical pricing data, regulatory changes, market demand, competition, and technological advancements[2].
How does the FDA update the NDC Directory?
The FDA updates the NDC Directory daily with information on active and certified finished and unfinished drugs submitted by labelers in structured product labeling (SPL) electronic listing files[1].
What is the significance of the US pharmaceutical market growth projections?
The US pharmaceutical market is projected to grow from $846.72 billion in 2022 to $1.28 trillion by 2030, driven by factors such as rising production capacity, greater approvals of generic drugs, and escalating R&D investments[2].
Sources
- FDA - National Drug Code Directory[1]
- DrugPatentWatch - Market Analysis and Price Projections for Drugs: Understanding the NDC System[2]
- AJMC - Understanding Price Growth in the Market for Targeted Oncology Therapies[3]
- FDA - National Drug Code Database Background Information[4]
- HealthData.gov - National Drug Code Directory[5]
More… ↓